Skip to main navigation
Cartesian Therapeutics, Inc
  • About Us
    • Leadership
    • Board of Directors
    • Advisors
  • Science
    • mRNA Cell Therapy
    • Proprietary Platform
    • Manufacturing
    • Publications & Presentations
  • Pipeline
    • Descartes-08
    • Descartes-15
  • Patients
    • Clinical Trials
    • Patient Resources
  • Careers
  • Investors
    • Overview
    • News & Events
    • Stock Information
    • Financial Information
    • Corporate Governance
    • Investor Resources

SEC Filing Details

Financial Information
  • SEC Filings
  • Annual Reports

Document Details

Form
DEF 14A
Filing Date
April 28, 2025
Document Date
December 31, 2024
Form Description
Official notification to shareholders of matters to be brought to a vote ("Proxy")
Filing Group
Proxy Filings
Company
Cartesian Therapeutics, Inc
Issuer
CARTESIAN THERAPEUTICS, INC.

Filing Formats

iXBRL
View HTML
Download PDF
Download DOC
Download XLS

XBRL

XBRL Viewer
EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
EX-101.DEF - XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT
EX-101.LAB - XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
EX-101.PRE - XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
XML - XBRL INSTANCE DOCUMENT
  • About Us
  • Science
  • Pipeline
  • Patients
  • Careers
  • Investors
  • Go to linkedin page
  • Go to Twitter page

7495 New Horizon Way, Frederick, MD 21703

info@cartesiantx.com

  • Global Privacy Notice
  • HCP Privacy Notice
  • Vendor Privacy Notice
  • Terms of Service
  • FCOI Policy
  • Expanded Access Policy
Cartesian Therapeutics, Inc

©2026 Cartesian Therapeutics, Inc. All Rights Reserved.